Cardiogenic ShockNorthwestern Cardiology Fellows Homepage:心源性休克西北心脏病学研究员主页精选文档PPT文档.ppt

上传人:sccc 文档编号:4681766 上传时间:2023-05-07 格式:PPT 页数:26 大小:974.50KB
返回 下载 相关 举报
Cardiogenic ShockNorthwestern Cardiology Fellows Homepage:心源性休克西北心脏病学研究员主页精选文档PPT文档.ppt_第1页
第1页 / 共26页
Cardiogenic ShockNorthwestern Cardiology Fellows Homepage:心源性休克西北心脏病学研究员主页精选文档PPT文档.ppt_第2页
第2页 / 共26页
Cardiogenic ShockNorthwestern Cardiology Fellows Homepage:心源性休克西北心脏病学研究员主页精选文档PPT文档.ppt_第3页
第3页 / 共26页
Cardiogenic ShockNorthwestern Cardiology Fellows Homepage:心源性休克西北心脏病学研究员主页精选文档PPT文档.ppt_第4页
第4页 / 共26页
Cardiogenic ShockNorthwestern Cardiology Fellows Homepage:心源性休克西北心脏病学研究员主页精选文档PPT文档.ppt_第5页
第5页 / 共26页
点击查看更多>>
资源描述

《Cardiogenic ShockNorthwestern Cardiology Fellows Homepage:心源性休克西北心脏病学研究员主页精选文档PPT文档.ppt》由会员分享,可在线阅读,更多相关《Cardiogenic ShockNorthwestern Cardiology Fellows Homepage:心源性休克西北心脏病学研究员主页精选文档PPT文档.ppt(26页珍藏版)》请在三一办公上搜索。

1、Outline,Overview of shock Hemodynamic ParametersPA catheter,complicationsDifferentiating Types of ShockCardiogenic ShockEtiologiesPathophysiologyClinical FindingsTreatment,SHOCK=Inadequate Tissue Perfusion,Mechanisms:Inadequate oxygen delivery Release of inflammatory mediatorsFurther microvascular c

2、hanges,compromised blood flow and further cellular hypoperfusionClinical Manifestations:Multiple organ failureHypotension,Hemodynamic Parameters,Systemic Vascular Resistance(SVR)Cardiac Output(CO)Mixed Venous Oxygen Saturation(SvO2)Pulmonary Capillary Wedge Pressure(PCWP)Central Venous Pressure(CVP)

3、,Normal Values,Differentiating Types of Shock,PA Catheter Complications,Path of PAC:central venous circulation R heart pulmonary artery.The proximal port is in R atrium,distal port in pulm arteryArrhythmiasRBBBPA rupturePAC related infectionPulmonary infarction,Cardiogenic Shock,Systemic hypoperfusi

4、on secondary to severe depression of cardiac output and sustained systolic arterial hypotension despite elevated filling pressures.,Cardiogenic Shock,EtiologiesPathophysiologyClinical/Hemodynamic CharacteristicsTreatment Options,Etiologies,Acute myocardial infarction/ischemiaLV failureVSRPapillary m

5、uscle/chordal rupture-severe MRVentricular free wall rupture with subacute tamponade,Other conditions complicating large MIsHemorrhageInfectionExcess negative inotropic or vasodilator medicationsPrior valvular heart diseaseHyperglycemia/ketoacidosisPost-cardiac arrestPost-cardiotomyRefractory sustai

6、ned tachyarrhythmiasAcute fulminant myocarditisEnd-stage cardiomyopathyHypertrophic cardiomyopathy with severe outflow obstructionAortic dissection with aortic insufficiency or tamponadePulmonary emboluSevere valvular heart disease-Critical aortic or mitral stenosis,Acute severe aortic or MR,Pathoph

7、ysiology,Clinical Findings,Physical Exam:elevated JVP,+S3,rales,oliguria,acute pulmonary edemaHemodynamics:dec CO,inc SVR,dec SvO2Initial evaluation:hemodynamics(PA catheter),echocardiography,angiography,4 Potential Therapies,PressorsIntra-aortic Balloon Pump(IABP)FibrinolyticsRevascularization:CABG

8、/PCIRefractory shock:ventricular assist device,cardiac transplantation,Pressors do not change outcome,Dopamine 10 vasoconstriction(alpha effects)Dobutamine positive inotrope,vasodilates,arrhythmogenic at higher dosesNorepinephrine(Levophed):vasoconstriction,inotropic stimulant.Should only be used fo

9、r refractory hypotension with dec SVR.Vasopression vasoconstrictionVASO and LEVO should only be used as a last resort,IABP is a temporizing measure,Augments coronary blood flow in diastoleBalloon collapse in systole creates a vacuum effect decreases afterloadDecrease myocardial oxygen demand,Indicat

10、ion for IABP,Contraindications to IABP,Significant aortic regurgitation or significant arteriovenous shunting Abdominal aortic aneurysm or aortic dissection Uncontrolled sepsis Uncontrolled bleeding disorder Severe bilateral peripheral vascular disease Bilateral femoral popliteal bypass grafts for s

11、evere peripheral vascular disease.,Complications of IABP,Cholesterol EmbolizationCVA Sepsis Balloon ruptureThrombocytopeniaHemolysisGroin InfectionPeripheral Neuropathy,Revascularization SHOCK trial,Overall 30-Day Survival in the Study,Hochman J et al.N Engl J Med 1999;341:625-634,SHOCK trial,Hochman J et al.N Engl J Med 1999;341:625-634,Copyright restrictions may apply.,Hochman,J.S.et al.JAMA 2006;295:2511-2515.,Kaplan-Meier Long-term Survival of All Patients and Those Discharged Alive Following Hospitalization,SHOCK 6 years later,Question 1,Answer,Question 2,Answer,Question 3,Answer,

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 教育教学 > 成人教育


备案号:宁ICP备20000045号-2

经营许可证:宁B2-20210002

宁公网安备 64010402000987号